blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0934269

EP0934269 - ANALOGS OF CC-1065 AND THE DUOCARMYCINS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.08.2002
Database last updated on 01.01.2025
Most recent event   Tooltip09.08.2002Application deemed to be withdrawnpublished on 25.09.2002  [2002/39]
Applicant(s)For all designated states
THE SCRIPPS RESEARCH INSTITUTE
10550 North Torrey Pines Road
La Jolla, CA 92037 / US
[N/P]
Former [1999/32]For all designated states
The Scripps Research Institute
10550 North Torrey Pines Road
La Jolla, CA 92037 / US
Inventor(s)01 / BOGER, Dale, L.
2819 Via Posada
La Jolla, CA 92037 / US
[1999/32]
Representative(s)Hedley, Nicholas James Matthew, et al
Kilburn & Strode LLP
Lancon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2000/06]Hedley, Nicholas James Matthew, et al
Stephenson Harwood One, St. Paul's Churchyard
London EC4M 8SH / GB
Former [1999/32]Gold, Tibor Z., et al
Stephenson Harwood One, St. Paul's Churchyard
London EC4M 8SH / GB
Application number, filing date97927807.430.05.1997
[1999/32]
WO1997US09076
Priority number, dateUS19960018860P31.05.1996         Original published format: US 18860 P
US19960023346P12.09.1996         Original published format: US 23346 P
[1999/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9745411
Date:04.12.1997
Language:EN
[1997/52]
Type: A1 Application with search report 
No.:EP0934269
Date:11.08.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 04.12.1997 takes the place of the publication of the European patent application.
[1999/32]
Search report(s)International search report - published on:US04.12.1997
(Supplementary) European search report - dispatched on:EP30.11.1999
ClassificationIPC:C07D403/06, A61K31/40, C07D487/04, C07D417/12, A61K31/425, C07D209/90
[2000/02]
CPC:
C07D403/06 (EP,US); C07D209/94 (EP,US); C07D209/96 (EP,US);
C07D417/14 (EP,US); C07D487/10 (EP,US)
Former IPC [1999/32]C07D209/90, C07D403/02, C07D403/14, C07D403/06, C07D417/14, A61K31/40, C07D473/04, C07D417/12, A61K31/425
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1999/32]
Extension statesAL20.11.1998
LT20.11.1998
LV20.11.1998
RO20.11.1998
SI20.11.1998
TitleGerman:ANALOGE VON CC-1065 UND DUOCARMYCINE[1999/32]
English:ANALOGS OF CC-1065 AND THE DUOCARMYCINS[1999/32]
French:ANALOGUES DE CC-1065 ET DUOCARMYCINES[1999/32]
Entry into regional phase20.11.1998National basic fee paid 
20.11.1998Search fee paid 
20.11.1998Designation fee(s) paid 
20.11.1998Examination fee paid 
Examination procedure16.12.1997Request for preliminary examination filed
International Preliminary Examining Authority: US
20.11.1998Examination requested  [1999/32]
12.11.2001Despatch of a communication from the examining division (Time limit: M04)
23.03.2002Application deemed to be withdrawn, date of legal effect  [2002/39]
26.04.2002Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2002/39]
Fees paidRenewal fee
12.05.1999Renewal fee patent year 03
15.05.2000Renewal fee patent year 04
31.05.2001Renewal fee patent year 05
31.05.2002Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO9732850  (SCRIPPS RESEARCH INST [US], et al) [E] 1,2 * claim 1 *;
 [A]EP0680964  (UNIV SANTIAGO COMPOSTELA [ES]) [A] 3 * claim 1 *;
 [PX]  - BOGER D L ET AL, "Examination Of The Role Of The Duocarmycin SA Methoxy Substituents: Identification Of The Minimum, Fully Potent DNA Binding Subunit", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,GB,OXFORD, vol. 6, no. 18, ISSN 0960-894X, page 2207-2210, XP004135686 [PX] 3 * page 2207 *

DOI:   http://dx.doi.org/10.1016/0960-894X(96)00401-5
 [PX]  - BOGER ET AL, "Duocarmycin SA Shortened, Simplified, and Extended Agents: A Systematic Examination of the Role of the DNA Binding Subunit", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY,US,AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, vol. 119, no. 21, ISSN 0002-7863, page 4977-4986-4986, XP002106676 [PX] 3 * examples 23-25 *

DOI:   http://dx.doi.org/10.1021/ja9637208
 [PX]  - BOGER D L ET AL, "pH dependence of the rate of DNA alkylation for (+)-duocarmycin SA and (+)-CCBI-TMI", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,GB,OXFORD, vol. 7, no. 2, ISSN 0960-894X, page 233-238, XP004135999 [PX] 1 * example 3 *

DOI:   http://dx.doi.org/10.1016/S0960-894X(96)00605-1
 [PX]  - BOGER ET AL, "Synthesis, X-ray Structure, and Properties of Fluorocyclopropane Analogs of the Duocarmycins Incorporating the 9,9-Difluoro-1,2,9,9a-tetrahydrocyclopropa[c]benzo[e]indol-4-one (F2CBI) Alkylation Subunit", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY,US,AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, vol. 118, no. 37, ISSN 0002-7863, page 8860-8870-8870, XP002106677 [PX] 7 * See Fig 1 where X is F. *

DOI:   http://dx.doi.org/10.1021/ja961888n
 [X]  - BOGER D L ET AL, "CBI-CDPBO1 and CBI-CDPBI1: CC-1065 analogs containing deep-seated modifications in the DNA binding subunit", BIOORGANIC & MEDICINAL CHEMISTRY,GB,ELSEVIER SCIENCE LTD, vol. 3, no. 6, ISSN 0968-0896, page 761-775, XP002086065 [X] 1,2 * page 766; example 40 *

DOI:   http://dx.doi.org/10.1016/0968-0896(95)00066-P
 [X]  - BOGER D L ET AL, "1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogs of CC-1065 and the duocarmycins: synthesis and evaluation", BIOORGANIC & MEDICINAL CHEMISTRY,GB,ELSEVIER SCIENCE LTD, vol. 3, no. 11, ISSN 0968-0896, page 1429-1453, XP002086069 [X] 3 * the whole document *

DOI:   http://dx.doi.org/10.1016/0968-0896(95)00130-9
 [X]  - BOGER D L ET AL, "A Hammett correlation for CC-1065 and duocarmycin analogs: magnitude of substituent electronic effects on functional reactivity", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,GB,OXFORD, (199602), vol. 6, no. 6, ISSN 0960-894X, page 659-664, XP004135001 [X] 1 * page 661; example 15 *

DOI:   http://dx.doi.org/10.1016/0960-894X(96)00093-5
 [A]  - BOGER D L ET AL, "CC-1065 CBI analogs: an example of enhancement of DNA alkylation efficiency through introduction of stabilizing electrostatic interactions", BIOORGANIC & MEDICINAL CHEMISTRY,GB,ELSEVIER SCIENCE LTD, vol. 3, no. 6, ISSN 0968-0896, page 611-621, XP002086064 [A] 3

DOI:   http://dx.doi.org/10.1016/0968-0896(95)00048-L
International search[YP]WO9712862
 [YP]  - DATABASE WPIDS ON STN, Week 9721, Columbus, Ohio, USA, DERWENT INFORMATION LTD., AN 97-235552; & WO,A,97 12862 (SCRIPPS RESEARCH INSTITUTE), April 1997., & WO9712862 A 00000000
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.